View logs for this pageFilter revisionsExpandCollapseTo date:Tag filter: Show revisions Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom. Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit. curprev 15:19, 27 March 2023 194.36.99.7 talk 3,876 bytes +3,876 Created page with "CONCLUSIONS Ruxolitinib, compared with placebo, supplied considerable medical advantages throughout people with myelofibrosis by reducing spleen dimension, ameliorating incapa..."